Precision medicine in gestational trophoblastic disease
- Author:
Agnes L. Soriano‑Estrella
1
Author Information
- Publication Type:Journal Article
- MeSH: Gestational Trophoblastic Disease; Hydatidiform Mole; Precision Medicine
- From: Philippine Journal of Obstetrics and Gynecology 2023;47(3):95-98
- CountryPhilippines
- Language:English
- Abstract: Precision medicine is a form of medicine that utilizes information about a person’s own genes to prevent, diagnose, or treat disease. In trophoblastic disease, precision medicine is important for accurate diagnosis, risk stratification, prognostication, and management. Immunohistochemistry, particularly p57kip2, has become an important ancillary procedure for the accurate identification of complete hydatidiform mole (HM). Molecular genotyping, on the other hand, is now considered the gold standard for the accurate classification of HM. Both tests are important for prognostication and the determination of the appropriate follow‑up plan. For gestational trophoblastic neoplasia, immunohistochemical markers can confirm the histologic diagnosis of its various types. Molecular genotyping differentiates gestational from nongestational tumors with overlapping histology and allows for precise identification of the index or causative pregnancy of a choriocarcinoma.
- Full text:precision_medicine_in_gestational_trophoblastic.1.pdf
